Results 221 to 230 of about 13,097 (241)
Some of the next articles are maybe not open access.
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, 2016
Podoplanin (PDPN) is a type-I transmembrane sialoglycoprotein, which possesses a platelet aggregation-stimulating (PLAG) domain in its N-terminus. Among the three PLAG domains, O-glycan on Thr52 of PLAG3 is critical for the binding with C-type lectin-like receptor-2 (CLEC-2) and is essential for platelet-aggregating activity of PDPN. Although many anti-
Yukinari, Kato +17 more
openaire +2 more sources
Podoplanin (PDPN) is a type-I transmembrane sialoglycoprotein, which possesses a platelet aggregation-stimulating (PLAG) domain in its N-terminus. Among the three PLAG domains, O-glycan on Thr52 of PLAG3 is critical for the binding with C-type lectin-like receptor-2 (CLEC-2) and is essential for platelet-aggregating activity of PDPN. Although many anti-
Yukinari, Kato +17 more
openaire +2 more sources
Podoplanin expression in oral leukoplakia: Tumorigenic role
Oral Oncology, 2013Recent studies have identified podoplanin, a mucin-type transmembrane glycoprotein, as a biomarker for oral cancer risk in patients with oral leukoplakia (OPL). The aim of this study was to investigate the potential association between podoplanin and the risk of malignant transformation of OPL with epithelial dysplasia.In this retrospective study ...
Juan Carlos, de Vicente +5 more
openaire +2 more sources
PMab-44 Detects Bovine Podoplanin in Immunohistochemistry
Monoclonal Antibodies in Immunodiagnosis & Immunotherapy, 2016Podoplanin (PDPN)/Aggrus is a type I transmembrane O -glycoprotein, which is expressed in several normal tissues including podocytes of kidney and lymphatic endothelial cells. PDPN activates platelet aggregation by binding to C-type lectin-like receptor-2 (CLEC-2) on platelet; however, only ...
Ryusuke, Honma +8 more
openaire +2 more sources
Podoplanin: A Novel Diagnostic Immunohistochemical Marker
Advances in Anatomic Pathology, 2006Podoplanin is a transmembrane mucoprotein recognized by the recently commercially available D2-40 monoclonal antibody. Recent investigations have shown that podoplanin is selectively expressed in lymphatic endothelium as well as lymphangiomas, Kaposi sarcomas, and in a subset of angiosarcomas with probable lymphatic differentiation. Podoplanin has also
openaire +2 more sources
Hybridoma, 2008
Podoplanin (Aggrus) is a mucin-type sialoglycoprotein that is known as a useful marker for lymphatic endothelium and tumor-initiating cells (TICs). Interaction between podoplanin and C-type lectin-like receptor-2 (CLEC-2) is reported to be critical for podoplanin-induced platelet aggregation and cancer metastasis.
Satoshi, Ogasawara +3 more
openaire +2 more sources
Podoplanin (Aggrus) is a mucin-type sialoglycoprotein that is known as a useful marker for lymphatic endothelium and tumor-initiating cells (TICs). Interaction between podoplanin and C-type lectin-like receptor-2 (CLEC-2) is reported to be critical for podoplanin-induced platelet aggregation and cancer metastasis.
Satoshi, Ogasawara +3 more
openaire +2 more sources
PMab-210: A Monoclonal Antibody Against Pig Podoplanin
Monoclonal Antibodies in Immunodiagnosis & Immunotherapy, 2019Podoplanin (PDPN) is a type I transmembrane glycoprotein that is expressed in normal tissues, including renal corpuscles and type I lung alveolar cells. Monoclonal antibodies (mAbs) against human, mouse, rat, rabbit, dog, cat, and bovine PDPNs have already been established; however, antipig PDPN (pPDPN) mAbs have not.
Yoshikazu, Furusawa +12 more
openaire +2 more sources
Blocking podoplanin inhibits platelet activation and decreases cancer-associated venous thrombosis.
Thrombosis Research, 2021Xia Wang +9 more
semanticscholar +1 more source

